Association between TP53 R249S mutation and polymorphisms in TP53 intron 1 in hepatocellular carcinoma

被引:12
|
作者
Ortiz-Cuaran, Sandra [1 ]
Cox, David [2 ]
Villar, Stephanie [1 ]
Friesen, Marlin D. [3 ]
Durand, Geoffroy [1 ]
Chabrier, Amelie [1 ]
Khuhaprema, Thiravud [4 ]
Sangrajrang, Suleeporn [4 ]
Ognjanovic, Simona [5 ,6 ]
Groopman, John D. [3 ]
Hainaut, Pierre [1 ]
Le Calvez-Kelm, Florence [1 ]
机构
[1] Int Agcy Res Canc, F-69372 Lyon, France
[2] Canc Res Ctr Lyon, INSERM, U1052, Lyon, France
[3] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA
[4] Natl Canc Inst, Bangkok, Thailand
[5] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA
[6] Int Prevent Res Inst, Lyon, France
来源
GENES CHROMOSOMES & CANCER | 2013年 / 52卷 / 10期
关键词
P53; CANCER; DNA; VARIANTS; PATHWAY; RISK;
D O I
10.1002/gcc.22086
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Over 100 single nucleotide polymorphisms (SNP) are validated in the TP53 tumor suppressor gene. They define haplotypes, which may differ in their activities. Therefore, mutation in cancer may occur at different rates depending upon haplotypes. However, these associations may be masked by differences in mutations types and causes of mutagenesis. We have analyzed the associations between 19 SNPs spanning the TP53 locus and a single specific aflatoxin-induced TP53 mutation (R249S) in 85 in hepatocellular carcinoma cases and 132 controls from Thailand. An association with R249S mutation (P=0.007) was observed for a combination of two SNPs (rs17882227 and rs8064946) in a linkage disequilibrium block extending from upstream of exon 1 to the first half of intron 1. This domain contains two coding sequences overlapping with TP53 (WRAP53 and Hp53int1) suggesting that sequences in TP53 intron 1 encode transcripts that may modulate R249S mutation rate in HCC. (c) 2013 Wiley Periodicals, Inc.
引用
收藏
页码:912 / 919
页数:8
相关论文
共 50 条
  • [1] TP53 R249S mutation, genetic variations in HBX and risk of hepatocellular carcinoma in The Gambia
    Gouas, Doriane A.
    Villar, Stephanie
    Ortiz-Cuaran, Sandra
    Legros, Penelope
    Ferro, Gilles
    Kirk, Gregory D.
    Lesi, Olufunmilayo A.
    Mendy, Maimuna
    Bah, Ebrima
    Friesen, Marlin D.
    Groopman, John
    Chemin, Isabelle
    Hainaut, Pierre
    CARCINOGENESIS, 2012, 33 (06) : 1219 - 1224
  • [2] HIGH CHROMOSOME INSTABILITY AND OCCASIONAL R249S TP53 MUTATION CHARACTERIZE HEPATOCELLULAR CARCINOMA IN ROMANIA
    Marchio, A.
    Tanase, A. -M.
    Dumitrascu, T.
    Mihaila, M.
    Dima, S.
    Dejean, A.
    Popescu, I.
    Oprisan, G.
    Pineau, P.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S229 - S230
  • [3] Hepatitis B Virus Genetic Variation and TP53 R249S Mutation in Patients with Hepatocellular Carcinoma in Thailand
    Thongbai, Chureeporn
    Sa-nguanmoo, Pattaratida
    Kranokpiruk, Pavanrat
    Poovorawan, Kittiyod
    Poovorawan, Yong
    Tangkijvanich, Pisit
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (06) : 3555 - 3559
  • [4] TP53 R249S mutation in hepatic organoids captures the predisposing cancer risk
    Lam, Yin Kau
    Yu, Jianqing
    Huang, Hao
    Ding, Xiaofan
    Wong, Alissa M.
    Leung, Howard H.
    Chan, Anthony W.
    Ng, Kelvin K.
    Xu, Mingjing
    Wang, Xin
    Wong, Nathalie
    HEPATOLOGY, 2023, 78 (03) : 727 - 740
  • [5] METABOLIC SYNDROME INSTEAD OF AFLATOXIN-RELATED TP53 R249S MUTATION AS A HEPATOCELLULAR CARCINOMA RISK FACTOR
    Valdes-Peregrina, Estefanie N.
    Sanchez-Hernandez, Beatriz E.
    Gamboa-Dominguez, Armando
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2020, 72 (05): : 316 - 322
  • [6] Aflatoxin-Induced TP53 R249S Mutation in HepatoCellular Carcinoma in Thailand: Association with Tumors Developing in the Absence of Liver Cirrhosis
    Villar, Stephanie
    Ortiz-Cuaran, Sandra
    Abedi-Ardekani, Behnoush
    Gouas, Doriane
    da Costa, Andre Nogueira
    Plymoth, Amelie
    Khuhaprema, Thiravud
    Kalalak, Anant
    Sangrajrang, Suleeporn
    Friesen, Marlin D.
    Groopman, John D.
    Hainaut, Pierre
    PLOS ONE, 2012, 7 (06):
  • [7] TP53 and hepatocellular carcinoma
    Puisieux, A
    Ozturk, M
    PATHOLOGIE BIOLOGIE, 1997, 45 (10): : 864 - 870
  • [8] Lack of hotspot mutations other than TP53 R249S in aflatoxin B1 associated hepatocellular carcinoma
    Akyerli, Cemaliye B.
    Yuksel, Sirin K.
    Yakicier, M. Cengiz
    TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2020, 45 (04): : 451 - 453
  • [9] Association between HBX status, aflatoxin-induced R249S TP53 mutation and risk of hepatocellular carcinoma in a case-control study from Thailand
    Ortiz-Cuaran, Sandra
    Villar, Stephanie
    Gouas, Doriane
    Ferro, Gilles
    Plymoth, Amelie
    Khuhaprema, Thiravud
    Kalalak, Anant
    Sangrajrang, Suleeporn
    Friesen, Marlin D.
    Groopman, John D.
    Hainaut, Pierre
    CANCER LETTERS, 2013, 331 (01) : 46 - 51
  • [10] TP53 mutation in ovarian carcinoma
    Murphy, M
    McManus, DT
    Toner, PG
    Russell, SEH
    EUROPEAN JOURNAL OF CANCER, 1997, 33 (08) : 1281 - 1283